May 08, 2018 12:05 pm UTC| Business
-- Addition of Senior Executive with Significant Process Science Experience Supports Company’s Efforts to Expand and Enhance Process Development Capabilities -- TUSTIN, Calif., May 08, 2018 -- Avid Bioservices, Inc....
TransUnion to Present at Barclays Americas Select Franchise Conference
May 08, 2018 12:05 pm UTC| Business
CHICAGO, May 08, 2018 -- TransUnion (NYSE:TRU) today announced that Todd Cello, CFO, will present at the Barclays Americas Select Franchise Conference in London on Tuesday, May 15, 2018. The presentation is scheduled to...
CBRS Alliance Launches OnGo™ Brand and OnGo Certification Program
May 08, 2018 12:02 pm UTC| Business
WASHINGTON, May 08, 2018 -- Today, at its Annual Members Meeting, the CBRS Alliance launched the OnGo™ brand. OnGo represents uncompromised wireless connectivity – enabled by spectrum sharing in the 3.5 GHz band – that...
Vystar Pays Off $1.1 Million of Long-Term Convertible Debt at 30% savings
May 08, 2018 12:02 pm UTC| Business
All $1.1 million of long-term convertible debt paid off for $795,00085% of debt converted is held by current insiders large stakeholdersVystar CEO progresses on plan to eliminate all debt WORCESTER, Mass., May 08, 2018 ...
May 08, 2018 12:02 pm UTC| Business
RENO, Nev., May 08, 2018 -- Ormat Technologies Inc. (NYSE:ORA) today announced that NIL 2, the third unit of the Sarulla geothermal power plant, has commenced commercial operation, bringing the project to its full...
Microchip Technology Announces Financial Results for Fourth Quarter and Fiscal Year 2018
May 08, 2018 12:02 pm UTC| Business
For the quarter ended March 31, 2018 GAAP and Non-GAAP net sales of $1.002 billion, up 0.8% sequentially and up 11.0% from the year ago quarter. The midpoint of our guidance provided on March 1, 2018 was net sales of...
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results
May 08, 2018 12:02 pm UTC| Business
-On track to begin CTX001 clinical study in hemoglobinopathies in 2018--On track to file IND in 2018 for CTX101, allogeneic CRISPR-based CAR-T targeted toward CD19+ malignancies--$341.8 million in cash as of March 31,...